|
Recent advances
in biophotonics have been pivotal in opening the new
frontier “optical diagnosis” in medicine. These advances
have the great potential to revolutionize the early,
accurate, noninvasive, real-time, and cost-effective
detection of diseases, to monitor treatment
responses, and to identify tumor
margins as real-time surgical guidance.
Our major
research interests include:
1) To develop
advanced biophotonics technologies for the early and
accurate detection of diseases, in particular, cancers, for
monitoring efficacy of chemotherapy, and for intraoperative
surgical guidance,
2) To translate
promising technologies to clinical settings and epidemiology
as tools for measures of outcomes,
3) To provide
important insights into cancer biology using the promising
technologies, and
4) To understand
light propagation and light-tissue interaction in biological
tissue.
We envision that
our innovation will be crucial to patients undergoing cancer
screening or treatment, to clinicians developing effective
screening and treatment strategies, to pharmaceutical
companies developing or evaluating new agents, to biomedical
researchers investigating mechanisms of carcinogenesis, and
to epidemiologists studying diseases in populations.
|
